GNAO1 and Encephalopathy: By utilizing C. elegans, researchers can gain deeper insights into the mechanisms underlying GNAO1 encephalopathy and develop targeted treatments that address the complex interplay of motor dysfunctions, seizures, and developmental delays characteristic of this disorder.